REG - Ovoca Bio PLC - Director/PDMR Shareholding

Ovoca BioAnnouncement

15/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240715:nRSO3002Wa&default-theme=true

RNS Number : 3002W  Ovoca Bio PLC  15 July 2024

Notification of Transactions by Persons Discharging Managerial
Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of
Regulation (EU) No 596/2014 of the European Parliament and of the Council of
16 April 2014 on market abuse (Market Abuse Regulation)

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated

 a)  Name

                                                 Timothy McCutcheon


 2   Reason for the notification

 a)  Position/status

                                                 Non-Executive Director, PDMR

 b)  Initial Notification Amendment

                                                 Initial Notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                        Ovoca Bio plc

 b)  LEI                                         213800ST2AK5XQ1O5207

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial  instrument,

     type  of                                    Ordinary Shares of nominal value €0.125 each

     instrument

     Identification code                         ISIN: IE00B4XVDC01
 b)  Nature of the transaction

                                                 Purchase of Ordinary Shares

 c)  Price(s) and volume(s)

Price(s)              Volume(s)
                                                 0.85 pence per share  19,506,203

 

 d)  Aggregated information

     - Aggregated volume

     - Price                                     N/A (Single Transaction)

 e)  Date of the transaction

                                                 12 July 2024

 f)  Place of the transaction

                                                 Outside of a trading venue

 g)  Additional Information

                                                 Following this transaction, Mr McCutcheon has an interest in 19,506,203
                                                 Ordinary Shares in Ovoca Bio plc, or 23.92% of the Issued Share Capital of the
                                                 Company (excl. Treasury Shares)

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

e)

Date of the transaction

 

12 July 2024

 

f)

Place of the transaction

 

Outside of a trading venue

 

g)

Additional Information

 

Following this transaction, Mr McCutcheon has an interest in 19,506,203
Ordinary Shares in Ovoca Bio plc, or 23.92% of the Issued Share Capital of the
Company (excl. Treasury Shares)

 

Notification of Transactions by Persons Discharging Managerial
Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of
Regulation (EU) No 596/2014 of the European Parliament and of the Council of
16 April 2014 on market abuse (Market Abuse Regulation)

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated

 a)  Name

                                                 Kirill Golovanov

 2   Reason for the notification

 a)  Position/status

                                                 Chief Executive Officer, PDMR

 b)  Initial Notification Amendment

                                                 Initial Notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                        Ovoca Bio plc

 b)  LEI                                         213800ST2AK5XQ1O5207

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial  instrument,

     type  of                                    Ordinary Shares of nominal value €0.125 each

     instrument

     Identification code                         ISIN: IE00B4XVDC01
 b)  Nature of the transaction

                                                 Disposal of Ordinary Shares

 c)  Price(s) and volume(s)

Price(s)              Volume(s)
                                                 0.85 pence per share  19,506,203

 

 d)  Aggregated information

     - Aggregated volume

     - Price                                     N/A (Single Transaction)

 e)  Date of the transaction

                                                 12 July 2024

 f)  Place of the transaction

                                                 Outside of a trading venue

 g)  Additional Information

                                                 Following this transaction, Mr. Golovanov no longer holds any Ordinary Shares
                                                 in Ovoca Bio plc

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

12 July 2024

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

g)

Additional Information

 

Following this transaction, Mr. Golovanov no longer holds any Ordinary Shares
in Ovoca Bio plc

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEAKXAFALLEFA